Corcept Therapeutics | CORT - Ebit

Aktienkurs
34.64
Täglich Wechseln
0.56 1.64%
Monatlich
-1.98%
Jährlich
-40.95%
Q1 Prognose
33.60




Ebit Veränderung Datum
Acadia Pharmaceuticals USD 17.39M 18.36M 2025-12
Alaunos Therapeutics USD -1.19M 148K 2025-09
ANI Pharmaceuticals USD 29.13M 6.3M 2025-12
Ardelyx USD 5.1M 2.02M 2025-12
Aurora Cannabis CAD -35.79M 8.96M 2025-12
BioMarin Pharmaceutical USD 198.39M 230.08M 2025-12
Bristol-Myers Squibb USD 3.47B 567M 2025-12
Canopy Growth CAD -12.66M 1.64M 2025-12
Corcept Therapeutics USD 4.49M 5.73M 2025-12
Eli Lilly USD 8.99B 1.57B 2025-12
Esperion Therapeutics USD 85.23M 95.19M 2025-12
J&J USD 5.11B 2.3B 2025-12
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Lexicon Pharmaceuticals USD -14.78M 2.59M 2025-12
Merck USD 6.24B 1.32B 2025-12
Nektar Therapeutics USD -34.34M 3.68M 2024-09
Novartis USD 4.06B 530M 2025-12
Novartis USD 4.06B 413M 2025-12
Omeros USD -48.15M 7.25M 2023-09
Pacira USD 3.19M 9.96M 2025-12
Pfizer USD 4.65B 71M 2025-12
Supernus Pharmaceuticals USD 13.82M 74.01M 2025-12
TG Therapeutics USD 50.49M 21.13M 2025-12